Adrenaline-boosting experiences to treat or alleviate depression symptoms
Image credit: Getty Images
Please leave the feedback on this idea
Is it original or innovative?
Is it feasible?
Is it targeting an unsolved problem?
Is it concisely described?
Bounty for the best solution
Provide a bounty for the best solution
Bounties attract serious brainpower to the challenge.
- Adrenaline plays an important role in both the pathophysiology and treatment of depression. Many antidepressants work by increasing adrenaline levels in the brain . Even though intense experiences create a so-called adrenaline rush which is rather short-lived and not a constant increase in adrenaline levels, they are a natural approach to boosting adrenaline.
- During the adrenaline rush a person usually experiences increased energy and motivation, this is what people suffering from depression constantly lack and even a short experience of an improved condition might give a psychological push with lasting positive effects.
- Extreme experiences are relatively harmless health-wise (compared to other means that might give a neurochemical boost like alcohol and drugs to which depressed people often turn) they are abundantly available and the only limitation for engaging in safe extreme experiences often might be a lack of finances which can be solved by allowances/governmental funding.
- Intentional self-injury is a common phenomenon among people experiencing depressive symptoms. A psychological explanation for this is that it gives them temporary relief from negative emotions, a sort of grounding experience, feeling alive due to the ability to experience pain, something intense rather than numbed feelings. But the adrenaline release due to injury might very well contribute to this. Extreme experiences causing fear and excitement without physical injury seem like a better alternative.
Why it should work
- four norepinephrine reuptake inhibitors which work by increasing the synaptic activity of adrenaline in the brain
- four selective serotonin reuptake inhibitors which elicit their effects by increasing the activity of serotonin in the brain (Prozac, Zoloft, Paxil, Celexa)